InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Gollob Jared, Directeur Médical. Officer active across 2 companies, notably Kymera Therapeutics, Inc.. Aggregated, 13 filings have been logged. Activity tracked since 1 November 2021. The latest transaction was filed on 2 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Gollob Jared
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
17,650 shares0Common StockSEC:0001193125-26-091983:0
49,307 shares@ US$5.3354.3% of flowCommon StockSEC:0001193125-25-311503:0
28,999 shares@ US$1.3117.2% of flowCommon StockSEC:0001193125-25-240430:0
800 shares@ US$1.310.5% of flowCommon StockSEC:0001193125-25-239144:0
30,000 shares0Common StockSEC:0000950170-25-031144:0
16,455 shares@ US$2.0820.1% of flowCommon StockSEC:0000950170-24-084003:0
24,375 shares0Common StockSEC:0000950170-24-025101:0
400 shares@ US$2.080.5% of flowCommon StockSEC:0000950170-24-023168:0
46,137 shares@ US$2.0856.9% of flowCommon StockSEC:0000950170-24-013482:0
18,750 shares0Common StockSEC:0000899243-23-006981:0
10,208 shares@ US$1.313.0% of flowCommon StockSEC:0000899243-22-016538:0
12,600 shares0Common StockSEC:0000899243-22-009076:0
20,000 shares@ US$1.315.5% of flowCommon StockSEC:0000899243-21-042437:0
13 of 13 declarations
About Gollob Jared
Gollob Jared is Chief Medical Officer at Kymera Therapeutics, Inc. The 13 filings on record, with sampled data from 2021-11-02 to 2026-03-04, are described as option exercises. The buy and sell volumes shown for this sample are EUR 0 and EUR 0.
